167 related articles for article (PubMed ID: 26542501)
1. A randomized, double-blind, placebo-controlled trial to evaluate the safety and effectiveness of intracoronary application of a novel bioabsorbable cardiac matrix for the prevention of ventricular remodeling after large ST-segment elevation myocardial infarction: Rationale and design of the PRESERVATION I trial.
Rao SV; Zeymer U; Douglas PS; Al-Khalidi H; Liu J; Gibson CM; Harrison RW; Joseph DS; Heyrman R; Krucoff MW
Am Heart J; 2015 Nov; 170(5):929-37. PubMed ID: 26542501
[TBL] [Abstract][Full Text] [Related]
2. Bioabsorbable Intracoronary Matrix for Prevention of Ventricular Remodeling After Myocardial Infarction.
Rao SV; Zeymer U; Douglas PS; Al-Khalidi H; White JA; Liu J; Levy H; Guetta V; Gibson CM; Tanguay JF; Vermeersch P; Roncalli J; Kasprzak JD; Henry TD; Frey N; Kracoff O; Traverse JH; Chew DP; Lopez-Sendon J; Heyrman R; Krucoff MW
J Am Coll Cardiol; 2016 Aug; 68(7):715-23. PubMed ID: 27515331
[TBL] [Abstract][Full Text] [Related]
3. Intracoronary delivery of injectable bioabsorbable scaffold (IK-5001) to treat left ventricular remodeling after ST-elevation myocardial infarction: a first-in-man study.
Frey N; Linke A; Süselbeck T; Müller-Ehmsen J; Vermeersch P; Schoors D; Rosenberg M; Bea F; Tuvia S; Leor J
Circ Cardiovasc Interv; 2014 Dec; 7(6):806-12. PubMed ID: 25351198
[TBL] [Abstract][Full Text] [Related]
4. Effects of selective matrix metalloproteinase inhibitor (PG-116800) to prevent ventricular remodeling after myocardial infarction: results of the PREMIER (Prevention of Myocardial Infarction Early Remodeling) trial.
Hudson MP; Armstrong PW; Ruzyllo W; Brum J; Cusmano L; Krzeski P; Lyon R; Quinones M; Theroux P; Sydlowski D; Kim HE; Garcia MJ; Jaber WA; Weaver WD
J Am Coll Cardiol; 2006 Jul; 48(1):15-20. PubMed ID: 16814643
[TBL] [Abstract][Full Text] [Related]
5. Rationale and design of a double-blind, multicenter, randomized, placebo-controlled clinical trial of early administration of intravenous β-blockers in patients with ST-elevation myocardial infarction before primary percutaneous coronary intervention: EARLY β-blocker administration before primary PCI in patients with ST-elevation myocardial infarction trial.
Roolvink V; Rasoul S; Ottervanger JP; Dambrink JH; Lipsic E; van der Horst IC; de Smet B; Kedhi E; Marcel Gosselink AT; Piek JJ; Sanchez-Brunete V; Ibanez B; Fuster V; Van't Hof AW;
Am Heart J; 2014 Nov; 168(5):661-6. PubMed ID: 25440793
[TBL] [Abstract][Full Text] [Related]
6. Design and rationale of the Reduction of Infarct Expansion and Ventricular Remodeling with Erythropoietin after Large Myocardial Infarction (REVEAL) trial.
Melloni C; Rao SV; Povsic TJ; Melton L; Kim RJ; Kilaru R; Patel MR; Talan M; Ferrucci L; Longo DL; Lakatta EG; Najjar SS; Harrington RA
Am Heart J; 2010 Nov; 160(5):795-803.e2. PubMed ID: 21095264
[TBL] [Abstract][Full Text] [Related]
7. Randomized placebo controlled trial evaluating the safety and efficacy of single low-dose intracoronary insulin-like growth factor following percutaneous coronary intervention in acute myocardial infarction (RESUS-AMI).
Caplice NM; DeVoe MC; Choi J; Dahly D; Murphy T; Spitzer E; Van Geuns R; Maher MM; Tuite D; Kerins DM; Ali MT; Kalyar I; Fahy EF; Khider W; Kelly P; Kearney PP; Curtin RJ; O'Shea C; Vaughan CJ; Eustace JA; McFadden EP
Am Heart J; 2018 Jun; 200():110-117. PubMed ID: 29898838
[TBL] [Abstract][Full Text] [Related]
8. A randomized, double-blind, placebo-controlled study of the safety and efficacy of intravenous MCC-135 as an adjunct to primary percutaneous coronary intervention in patients with acute myocardial infarction: rationale and design of the evaluation of MCC-135 for left ventricular salvage in acute MI (EVOLVE) study.
Jang IK; Pettigrew V; Picard MH; Kowey PR; Demmel V; Zile MR; Tatsuno J; Wackers FJ; Hibberd M
J Thromb Thrombolysis; 2005 Dec; 20(3):147-53. PubMed ID: 16261287
[TBL] [Abstract][Full Text] [Related]
9. Rationale and design of the Cyclosporine to ImpRove Clinical oUtcome in ST-elevation myocardial infarction patients (the CIRCUS trial).
Mewton N; Cung TT; Morel O; Cayla G; Bonnefoy-Cudraz E; Rioufol G; Angoulvant D; Guerin P; Elbaz M; Delarche N; Coste P; Vanzetto G; Metge M; Aupetit JF; Jouve B; Motreff P; Tron C; Labeque JN; Steg PG; Cottin Y; Range G; Clerc J; Coussement P; Prunier F; Moulin F; Roth O; Belle L; Dubois P; Barragan P; Gilard M; Piot C; Colin P; Morice MC; Monassier JP; Ider O; Dubois-Randé JL; Unterseeh T; Lebreton H; Beard T; Blanchard D; Grollier G; Malquarti V; Staat P; Sudre A; Hansson MJ; Elmer E; Boussaha I; Jossan C; Torner A; Claeys M; Garcia-Dorado D; Ovize M;
Am Heart J; 2015 Jun; 169(6):758-766.e6. PubMed ID: 26027612
[TBL] [Abstract][Full Text] [Related]
10. Intracoronary administration of bone marrow-derived progenitor cells improves left ventricular function in patients at risk for adverse remodeling after acute ST-segment elevation myocardial infarction: results of the Reinfusion of Enriched Progenitor cells And Infarct Remodeling in Acute Myocardial Infarction study (REPAIR-AMI) cardiac magnetic resonance imaging substudy.
Dill T; Schächinger V; Rolf A; Möllmann S; Thiele H; Tillmanns H; Assmus B; Dimmeler S; Zeiher AM; Hamm C
Am Heart J; 2009 Mar; 157(3):541-7. PubMed ID: 19249426
[TBL] [Abstract][Full Text] [Related]
11. Granulocyte-colony stimulating factor for large anterior ST-elevation myocardial infarction: rationale and design of the prospective randomized phase III STEM-AMI OUTCOME trial.
Achilli F; Malafronte C; Cesana F; Maggiolini S; Mauro C; De Ferrari GM; Lenatti L; Tespili M; Pasqualini P; Gentile F; Capogrossi MC; Maggioni A; Maseri A; Pontone G; Colombo GI; Pompilio G;
Am Heart J; 2015 Oct; 170(4):652-658.e7. PubMed ID: 26386788
[TBL] [Abstract][Full Text] [Related]
12. Clinical aspects of left ventricular diastolic function assessed by Doppler echocardiography following acute myocardial infarction.
Poulsen SH
Dan Med Bull; 2001 Nov; 48(4):199-210. PubMed ID: 11767125
[TBL] [Abstract][Full Text] [Related]
13. Endothelial progenitor cells, microvascular obstruction, and left ventricular remodeling in patients with ST elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Porto I; De Maria GL; Leone AM; Dato I; D'Amario D; Burzotta F; Niccoli G; Trani C; Biasucci LM; Bolognese L; Crea F
Am J Cardiol; 2013 Sep; 112(6):782-91. PubMed ID: 23746481
[TBL] [Abstract][Full Text] [Related]
14. Effect of intracoronary streptokinase administered immediately after primary percutaneous coronary intervention on long-term left ventricular infarct size, volumes, and function.
Sezer M; Cimen A; Aslanger E; Elitok A; Umman B; Buğra Z; Yormaz E; Türkmen C; Adalet IS; Nişanci Y; Umman S
J Am Coll Cardiol; 2009 Sep; 54(12):1065-71. PubMed ID: 19744615
[TBL] [Abstract][Full Text] [Related]
15. Cyclosporine A in Reperfused Myocardial Infarction: The Multicenter, Controlled, Open-Label CYCLE Trial.
Ottani F; Latini R; Staszewsky L; La Vecchia L; Locuratolo N; Sicuro M; Masson S; Barlera S; Milani V; Lombardi M; Costalunga A; Mollichelli N; Santarelli A; De Cesare N; Sganzerla P; Boi A; Maggioni AP; Limbruno U;
J Am Coll Cardiol; 2016 Feb; 67(4):365-374. PubMed ID: 26821623
[TBL] [Abstract][Full Text] [Related]
16. Association between discharge heart rate and left ventricular adverse remodelling in ST segment elevation myocardial infarction patients treated with primary percutaneous coronary intervention.
Joyce E; Hoogslag GE; Leong DP; Fox K; Schalij MJ; Marsan NA; Bax JJ; Delgado V
Heart; 2013 Apr; 99(8):556-61. PubMed ID: 23468514
[TBL] [Abstract][Full Text] [Related]
17. Intracoronary ECG during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction predicts microvascular obstruction and infarct size.
Wong DT; Leung MC; Das R; Liew GY; Teo KS; Chew DP; Meredith IT; Worthley MI; Worthley SG
Int J Cardiol; 2013 Apr; 165(1):61-6. PubMed ID: 21875755
[TBL] [Abstract][Full Text] [Related]
18. Association between left ventricular global longitudinal strain and adverse left ventricular dilatation after ST-segment-elevation myocardial infarction.
Joyce E; Hoogslag GE; Leong DP; Debonnaire P; Katsanos S; Boden H; Schalij MJ; Marsan NA; Bax JJ; Delgado V
Circ Cardiovasc Imaging; 2014 Jan; 7(1):74-81. PubMed ID: 24186962
[TBL] [Abstract][Full Text] [Related]
19. Effects of Compound Danshen Dripping Pills on Ventricular Remodeling and Cardiac Function after Acute Anterior Wall ST-Segment Elevation Myocardial Infarction (CODE-AAMI): Protocol for a Randomized Placebo-Controlled Trial.
Wu YJ; Deng B; Wang SB; Qiao R; Zhang XW; Lu Y; Wang L; Gu SZ; Zhang YQ; Li KQ; Yu ZL; Wu LX; Zhao SB; Zhou SL; Yang Y; Wang LS
Chin J Integr Med; 2023 Dec; 29(12):1059-1065. PubMed ID: 37656413
[TBL] [Abstract][Full Text] [Related]
20. Effect of high-dose intracoronary adenosine administration during primary percutaneous coronary intervention in acute myocardial infarction: a randomized controlled trial.
Fokkema ML; Vlaar PJ; Vogelzang M; Gu YL; Kampinga MA; de Smet BJ; Jessurun GA; Anthonio RL; van den Heuvel AF; Tan ES; Zijlstra F
Circ Cardiovasc Interv; 2009 Aug; 2(4):323-9. PubMed ID: 20031735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
